Perphenazine-4-aminobutyrate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePerphenazine-4-aminobutyrate
Drug Alias NamePerphenazine GABA esterPerphenazine gamma-aminobutyrate mesylateAN-168CYP-1020BL-1020
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonistsDopamine D2 receptor antagonists
TargetsGamma-aminobutyric acid A receptorDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenRomania +[6] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiolinerx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCypress Bioscience IncBiolinerx Ltd
Active IndicationsN/A
Inactive IndicationsSchizophreniaDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG